Operose Advisors »

Quince Therapeutics shares owned by Operose Advisors

Quarter-by-quarter ownership of Quince Therapeutics shares owned by Operose Advisors from 13F filings

Historical chart of Operose Advisors investment in Quince Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Quince Therapeutics held by Operose Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quince Therapeutics by Operose Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9k 159 18.20

More positions owned by Operose Advisors

Vanguard Total Stock Market ETF Etf (VTI)
Vanguard High Dividend Yield ETF Etf (VYM)
Vanguard FTSE Developed Markets ETF Etf (VEA)
Schwab International Equity ETF Etf (SCHF)
Vanguard S&P 500 ETF Etf (VOO)
iShares Core S&P Small-Cap ETF Etf (IJR)
Invesco S&P 500 Equal Weight ETF Etf (RSP)
Spdr S&p 500 Etf Etf (SPY)
Vanguard Mid-Cap ETF Etf (VO)
Vanguard Mid-Cap Growth ETF Etf (VOT)
Broadcom Common (AVGO)
NVIDIA Corp Common (NVDA)
Apple Common (AAPL)
iShares Russell 2000 ETF Etf (IWM)
Advanced Micro Devices Common (AMD)

View all positions for Operose Advisors

Top funds holding Quince Therapeutics

Tudor Investment Corporation
Ikarian Capital
Millennium Management
Balyasny Asset Management
Susquehanna International
Squadron Capital Management
Shay Capital
Boothbay Fund Management
Jane Street
Vanguard Capital Management
Cormorant Asset Management
UBS Group
Vanguard Fiduciary Trust
BlackRock
Tower Research Capital

View all funds holding Quince Therapeutics